ArticleMethods in molecular biology (Clifton, N.J.)2025
Construction of Nanotube-Shaped mRNA Vehicles Using Self-Assembling Peptides.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mRNA delivery vehicle technology is one of the key factors in developing mRNA-based therapeutics and vaccines. The delivery vehicle must protect the mRNA from degradation, accurately deliver it across body barriers into the target tissue or cell, and properly regulate expression of the protein. Even though the stability and performance of mRNA delivery vehicles is highly dependent on their nanostructure, most vehicles were irregular spherical shapes. In this chapter, we describe a detailed protocol for fabricating nanotubular mRNA delivery vehicles using self-assembling peptide building blocks. We present design principles of the peptide building blocks and formulation strategies of mRNA-peptide complexes. Additionally, we cover methods for characterizing and assessing their thermodynamic stability and intracellular performance. These protocols should help facilitate the development of precisely structure-controlled mRNA delivery vehicles.
Indexed as
Identifiers
40877517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.